Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Cells were then incubated with anti-V5 antibody (Mouse monoclonal anti-V5 (clone SV5-pk1) BioRad MCA1630 - 1:1000) at 4 C overnight before incubating with fluorophore-tagged secondary antibody, DAPI and phalloidin
Cost Implications The paper presents a compelling economic analysis of PEC implementation in manufacturing scenarios: Material Costs: Comparable single-use material costs to traditional methods at multi-kg scale Potential for significant solvent reduction Lower infrastructure requirements for handling and storage Strategic Implications For organizations entering or expanding in the peptide therapeutics space, this research highlights several key benefits when exploring innovative purification technologies like catch-and-release: Infrastructure Investment Lower capital expenditure requirements Reduced facility space needs Simplified scaling pathway Operational Flexibility Easier handling of complex peptides Adaptable to various manufacturing scales Reduced dependency on specialized equipment Sustainability Benefits Potential for reduced solvent usage Lower environmental impact Improved workplace safety profile Looking Forward As the peptide therapeutics market continues to grow, particularly in the GLP-1 space, manufacturing efficiency will increasingly determine market success
.png)
Individual results vary significantly with starting weight, adherence, and concurrent lifestyle factors
Clinical trial registries and research publications are other good sources of up-to-date information.
.png)
thy r hiu qu bt tng, bn c th cn kin tr t 6 thng n 1 nm, ty c a v tnh trng sc t ban u
